Home
/
MAIA Biotechnology, Inc.
/
Financials
/
Quarterly
MAIA Biotechnology, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that MAIA Biotechnology, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2022
Sep 30, 2022
$0
Feb 6, 2023
Q2
2022
Jun 30, 2022
$0
Aug 22, 2022
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($8.90M)
Nov 7, 2025
Q2
2025
Jun 30, 2025
($5.35M)
Aug 11, 2025
Q3
2025
Jun 30, 2025
($5.35M)
Nov 7, 2025
Q3
2025
Mar 31, 2025
($4.52M)
Nov 7, 2025
Q2
2025
Mar 31, 2025
($4.52M)
Aug 11, 2025
Q3
2025
Sep 30, 2024
($2.74M)
Nov 7, 2025
Q3
2025
Jun 30, 2024
($8.88M)
Nov 7, 2025
Q2
2025
Jun 30, 2024
($8.88M)
Aug 11, 2025
Q3
2025
Mar 31, 2024
($8.07M)
Nov 7, 2025
Q2
2025
Mar 31, 2024
($8.07M)
Aug 11, 2025
Q2
2022
Jun 30, 2022
($3.31M)
Aug 22, 2022
Q2
2022
Jun 30, 2021
($3.43M)
Aug 22, 2022
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($9.36M)
Nov 7, 2025
Q2
2025
Jun 30, 2025
($5.17M)
Aug 11, 2025
Q1
2025
Mar 31, 2025
($5.43M)
May 9, 2025
Q3
2025
Sep 30, 2024
($4.19M)
Nov 7, 2025
Q2
2025
Jun 30, 2024
($3.82M)
Aug 11, 2025
Q1
2025
Mar 31, 2024
($3.95M)
May 9, 2025
Q3
2024
Sep 30, 2023
($4.96M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($4.66M)
Aug 9, 2024
Q1
2024
Mar 31, 2023
($4.18M)
May 14, 2024
Q3
2023
Sep 30, 2022
($5.10M)
Nov 7, 2023
Q2
2023
Jun 30, 2022
($3.44M)
Aug 8, 2023
Q1
2023
Mar 31, 2022
($3.44M)
May 8, 2023
Q3
2022
Sep 30, 2021
($2.23M)
Feb 6, 2023